ロード中...
Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study
BACKGROUND: Mirogabalin, which is approved for the treatment of peripheral neuropathic pain in Japan, is a ligand for the α2δ subunit of voltage-gated calcium channels. Both pregabalin and mirogabalin act as nonselective ligands at the α2δ-1 and α2δ-2 subunits. Mirogabalin has a unique binding profi...
保存先:
| 出版年: | J Orthop Surg Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7249688/ https://ncbi.nlm.nih.gov/pubmed/32456647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13018-020-01709-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|